{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:29:12Z","timestamp":1772915352803,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007253","name":"Nancy Taylor Foundation for Chronic Diseases","doi-asserted-by":"publisher","award":["3205042008"],"award-info":[{"award-number":["3205042008"]}],"id":[{"id":"10.13039\/100007253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Juvenile Idiopathic Arthritis (JIA) induces growth disturbances in affected joints. Fibroblast-like synoviocytes (FLS) play a crucial role in JIA pathogenesis. FLS overexpress bone morphogenetic protein 4 (BMP4) and have a chondrocyte-like phenotype. FLS contribute directly to joint growth disturbances through endochondral bone formation. We investigated the ability of methotrexate to inhibit BMP4 expression and alter the hypertrophic chondrocyte-like phenotype of JIA FLS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We selected primary cells from three subjects with persistent oligoarticular JIA, three subjects who eventually extended to a polyarticular disease course, which we termed extended-to-be (ETB), and three subjects who had polyarticular arthritis at time of diagnosis. We treated cells with methotrexate and two BMP4 inhibitors: noggin and chordin. We measured protein concentration from three chondrocyte cell markers: collagen II, aggrecan, and collagen X as well as BMP4.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>ColX, marker of chondrocyte hypertrophy, was significantly increased in polyarticular FLS when compared to both persistent FLS and ETB FLS, making polyarticular FLS the most like hypertrophic chondrocytes. Methotrexate caused significant decreases in BMP4 and ColX expression in persistent, ETB, and polyarticular FLS when compared to respective untreated cells. Ligand-binding BMP4 antagonists, noggin and chordin, caused significant decreases in ColX expression in FLS from all three disease courses and significant increases in collagen II protein, an early chondrocyte marker, when compared to respective untreated cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Methotrexate, the first-line therapy in the treatment of JIA, mimics BMP4 antagonists by effectively lowering BMP4 and ColX expression in FLS. Inhibiting FLS from undergoing hypertrophy could prevent these cells from contributing to joint growth disturbances via endochondral bone formation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-023-00940-6","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T19:02:58Z","timestamp":1704222178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Methotrexate inhibits BMP4 and abrogates the hypertrophic chondrocyte phenotype of synovial fibroblasts in juvenile idiopathic arthritis"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2685-2645","authenticated-orcid":false,"given":"Megan M.","family":"Simonds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel T.","family":"Freer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Marie C.","family":"Brescia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"10","key":"940_CR1","first-page":"1991","volume":"25","author":"RE Petty","year":"1998","unstructured":"Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25(10):1991\u20134.","journal-title":"J Rheumatol."},{"issue":"2","key":"940_CR2","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol."},{"issue":"10","key":"940_CR3","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1002\/art.10544","volume":"46","author":"MJ Al-Matar","year":"2002","unstructured":"Al-Matar MJ, Petty RE, Tucker LB, Malleson PN, Schroeder ML, Cabral DA. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis. Arthritis Rheum. 2002;46(10):2708\u201315.","journal-title":"Arthritis Rheum."},{"key":"940_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00003086-197101000-00013","volume":"74","author":"JJ Calabro","year":"1971","unstructured":"Calabro JJ, Katz RM, Maltz BA. A critical reappraisal of juvenile rheumatoid arthritis. Clin Orthop Relat Res. 1971;74:101\u201319.","journal-title":"Clin Orthop Relat Res."},{"issue":"3","key":"940_CR5","first-page":"579","volume":"30","author":"F Fantini","year":"2003","unstructured":"Fantini F, Gerloni V, Gattinara M, Cimaz R, Arnoldi C, Lupi E. Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup. J Rheumatol. 2003;30(3):579\u201384.","journal-title":"J Rheumatol."},{"issue":"10","key":"940_CR6","first-page":"552","volume":"82","author":"CW Fink","year":"1991","unstructured":"Fink CW. The clinical features, course, prognosis and treatment of juvenile arthritis. Recenti Prog Med. 1991;82(10):552\u201360.","journal-title":"Recenti Prog Med."},{"issue":"2","key":"940_CR7","first-page":"386","volume":"30","author":"B Flato","year":"2003","unstructured":"Flato B, Lien G, Smerdel A, Vinje O, Dale K, Johnston V, et al. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J Rheumatol. 2003;30(2):386\u201393.","journal-title":"J Rheumatol."},{"issue":"8","key":"940_CR8","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/1529-0131(200008)43:8<1858::AID-ANR23>3.0.CO;2-A","volume":"43","author":"S Guillaume","year":"2000","unstructured":"Guillaume S, Prieur AM, Coste J, Job-Deslandre C. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum. 2000;43(8):1858\u201365.","journal-title":"Arthritis Rheum."},{"issue":"6","key":"940_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/ard.2004.026591","volume":"64","author":"M Arkela-Kautiainen","year":"2005","unstructured":"Arkela-Kautiainen M, Haapasaari J, Kautiainen H, Vilkkumaa I, Malkia E, Leirisalo-Repo M. Favourable social functioning and health related quality of life of patients with JIA in early adulthood. Ann Rheum Dis. 2005;64(6):875\u201380.","journal-title":"Ann Rheum Dis."},{"issue":"12","key":"940_CR10","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/rheumatology\/41.12.1428","volume":"41","author":"JC Packham","year":"2002","unstructured":"Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford). 2002;41(12):1428\u201335.","journal-title":"Rheumatology (Oxford)."},{"issue":"3","key":"940_CR11","first-page":"343","volume":"142","author":"M Vostrejs","year":"1988","unstructured":"Vostrejs M, Hollister JR. Muscle atrophy and leg length discrepancies in pauciarticular juvenile rheumatoid arthritis. Am J Dis Child. 1988;142(3):343\u20135.","journal-title":"Am J Dis Child."},{"issue":"2","key":"940_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2106\/00004623-198163020-00005","volume":"63","author":"S Simon","year":"1981","unstructured":"Simon S, Whiffen J, Shapiro F. Leg-length discrepancies in monoarticular and pauciarticular juvenile rheumatoid arthritis. J Bone Joint Surg Am. 1981;63(2):209\u201315.","journal-title":"J Bone Joint Surg Am."},{"issue":"11","key":"940_CR13","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/1529-0131(199911)42:11<2330::AID-ANR11>3.0.CO;2-B","volume":"42","author":"DD Sherry","year":"1999","unstructured":"Sherry DD, Stein LD, Reed AM, Schanberg LE, Kredich DW. Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. Arthritis Rheum. 1999;42(11):2330\u20134.","journal-title":"Arthritis Rheum."},{"issue":"3","key":"940_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2165\/00002018-199005030-00005","volume":"5","author":"B Grillet","year":"1990","unstructured":"Grillet B, Dequeker J. Intra-articular steroid injection a risk-benefit assessment. Drug Saf. 1990;5(3):205\u201311.","journal-title":"Drug Saf."},{"issue":"5","key":"940_CR15","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/art.38336","volume":"66","author":"AC Brescia","year":"2014","unstructured":"Brescia AC, Simonds MM, McCahan SM, Fawcett PT, Rose CD. The role of transforming growth factor \u03b2 signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: dysregulation of transforming growth factor \u03b2 signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy. Arthritis Rheumatol (Hoboken, NJ). 2014;66(5):1352\u201362.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)."},{"issue":"1","key":"940_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12969-021-00556-8","volume":"19","author":"MM Simonds","year":"2021","unstructured":"Simonds MM, Schlefman AR, McCahan SM, Sullivan KE, Rose CD, Brescia AC. The culture microenvironment of juvenile idiopathic arthritis synovial fibroblasts is favorable for endochondral bone formation through BMP4 and repressed by chondrocytes. Pediatr Rheumatol. 2021;19(1):72.","journal-title":"Pediatr Rheumatol."},{"issue":"3","key":"940_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cytogfr.2005.04.001","volume":"16","author":"N Tsumaki","year":"2005","unstructured":"Tsumaki N, Yoshikawa H. The role of bone morphogenetic proteins in endochondral bone formation. Cytokine Growth Factor Rev. 2005;16(3):279\u201385.","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"940_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1359\/jbmr.2002.17.2.293","volume":"17","author":"D Zhang","year":"2002","unstructured":"Zhang D, Ferguson CM, O\u2019Keefe RJ, Puzas JE, Rosier RN, Reynolds PR. A role for the BMP antagonist chordin in endochondral ossification. J Bone Miner Res. 2002;17(2):293\u2013300.","journal-title":"J Bone Miner Res."},{"issue":"1","key":"940_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1440-169x.2002.00616.x","volume":"44","author":"BK Zehentner","year":"2002","unstructured":"Zehentner BK, Haussmann A, Burtscher H. The bone morphogenetic protein antagonist noggin is regulated by Sox9 during endochondral differentiation. Develop Growth Differ. 2002;44(1):1\u20139.","journal-title":"Develop Growth Differ."},{"issue":"3","key":"940_CR20","first-page":"297","volume":"9","author":"F Halle","year":"1991","unstructured":"Halle F, Prieur AM. Evaluation of methotrexate in the treatment of juvenile chronic arthritis according to the subtype. Clin Exp Rheumatol. 1991;9(3):297\u2013302.","journal-title":"Clin Exp Rheumatol."},{"issue":"13","key":"940_CR21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM198503283121310","volume":"312","author":"JH Klippel","year":"1985","unstructured":"Klippel JH, Decker JL. Methotrexate in rheumatoid arthritis. N Engl J Med. 1985;312(13):853\u20134.","journal-title":"N Engl J Med."},{"issue":"2","key":"940_CR22","first-page":"301","volume":"32","author":"JA Stebulis","year":"2005","unstructured":"Stebulis JA, Rossetti RG, Atez FJ, Zurier RB. Fibroblast-like synovial cells derived from synovial fluid. J Rheumatol. 2005;32(2):301\u20136.","journal-title":"J Rheumatol."},{"issue":"6","key":"940_CR23","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1186\/ar4398","volume":"15","author":"S Revu","year":"2013","unstructured":"Revu S, Nereg\u00e5rd P, af Klint E, Korotkova M, Catrina AI. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. Arthritis Res Ther. 2013;15(6):R205.","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"940_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13075-018-1554-7","volume":"20","author":"B Bergstr\u00f6m","year":"2018","unstructured":"Bergstr\u00f6m B, Carlsten H, Ekwall AH. Methotrexate inhibits effects of platelet-derived growth factor and interleukin-1\u03b2 on rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Res Ther. 2018;20(1):49.","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"940_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12969-020-00483-0","volume":"18","author":"MM Simonds","year":"2020","unstructured":"Simonds MM, Schlefman AR, McCahan SM, Sullivan KE, Rose CD, Brescia AC. Juvenile idiopathic arthritis fibroblast-like synoviocytes influence chondrocytes to alter BMP antagonist expression demonstrating an interaction between the two prominent cell types involved in endochondral bone formation. Pediatr Rheumatol Online J. 2020;18(1):89.","journal-title":"Pediatr Rheumatol Online J."},{"issue":"7","key":"940_CR26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1242\/dev.029926","volume":"136","author":"KN Retting","year":"2009","unstructured":"Retting KN, Song B, Yoon BS, Lyons KM. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development. 2009;136(7):1093\u2013104.","journal-title":"Development."},{"issue":"1","key":"940_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biocel.2007.06.009","volume":"40","author":"EJ Mackie","year":"2008","unstructured":"Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol. 2008;40(1):46\u201362.","journal-title":"Int J Biochem Cell Biol."},{"issue":"7","key":"940_CR28","doi-asserted-by":"publisher","first-page":"e0130078","DOI":"10.1371\/journal.pone.0130078","volume":"10","author":"S Thomas","year":"2015","unstructured":"Thomas S, Fisher KH, Snowden JA, Danson SJ, Brown S, Zeidler MP. Methotrexate is a JAK\/STAT pathway inhibitor. PLoS One. 2015;10(7):e0130078.","journal-title":"PLoS One."},{"issue":"42","key":"940_CR29","doi-asserted-by":"publisher","first-page":"15395","DOI":"10.1074\/jbc.RA119.010139","volume":"294","author":"Y Yang","year":"2019","unstructured":"Yang Y, Chung MR, Zhou S, Gong X, Xu H, Hong Y, et al. STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription. J Biol Chem. 2019;294(42):15395\u2013407.","journal-title":"J Biol Chem."},{"issue":"1","key":"940_CR30","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.1038\/s41467-021-27273-w","volume":"12","author":"S Zhou","year":"2021","unstructured":"Zhou S, Dai Q, Huang X, Jin A, Yang Y, Gong X, et al. STAT3 is critical for skeletal development and bone homeostasis by regulating osteogenesis. Nat Commun. 2021;12(1):6891.","journal-title":"Nat Commun."},{"issue":"10","key":"940_CR31","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/rheumatology\/keh296","volume":"43","author":"KJ Elliot","year":"2004","unstructured":"Elliot KJ, Millward-Sadler SJ, Wright MO, Robb JE, Wallace WH, Salter DM. Effects of methotrexate on human bone cell responses to mechanical stimulation. Rheumatology (Oxford). 2004;43(10):1226\u201331.","journal-title":"Rheumatology (Oxford)."}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00940-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T19:08:54Z","timestamp":1704222534000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00940-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["940"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00940-6","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Synovial fluid and synovial tissue samples were obtained from our Institutional Review Board-approved repository (IRB#84709\u201332). Patients who underwent clinically indicated arthrocentesis were offered inclusion into the repository and informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}